Nekton Capital’s Enfusion, Inc. ENFN Stock Holding History

Nekton Capital’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-43,611	Closed	-$449K	–	10
2024 Q4	$449K	Buy	+43,611	New	+$422K	1.18%	7

Other funds holding ENFN

FMC

FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

LECM

Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Nekton Capital's ENFN Position: Q1 2025 in Review

Nekton Capital sold out of Enfusion, Inc. (ENFN) in Q1 2025, closing a stake of 43,611 shares — an estimated $449K sold.

Nekton Capital first reported a position in ENFN in Q4 2024 and held it in 1 quarter. The position peaked at $449K in Q4 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

Nekton Capital reported no remaining Enfusion, Inc. position as of Q1 2025 after selling out during the quarter.
Nekton Capital sold 43,611 Enfusion, Inc. shares in Q1 2025, an estimated $449K.
Nekton Capital first reported a position in Enfusion, Inc. in Q4 2024 and held it in 1 quarter.
Nekton Capital's Enfusion, Inc. position peaked at $449K in Q4 2024.
132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on Nekton Capital's 13F filing for Q1 2025, filed 12 May 2025.